Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in anti-HIV structure-based drug design

M J Gait1, J Karn

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Trends in Biotechnology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral immune dysfunction is associated with the expansion of FOXP3<sup>+</sup>PD-1<sup>+</sup>Amphiregulin<sup>+</sup> T cells during HIV infection.

Nature communications·2021
Same author

The rapid non-polar transport of auxin in the phloem of intact Coleus plants.

Planta·2014
Same author

Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.

Cellular and molecular life sciences : CMLS·2009
Same author

Simultaneous Visualization of Vasopressin and Oxytocin mRNA- Containing Neurons in the Hypothalamus Using Non-Radioactive in situ Hybridization Histochemistry.

Journal of neuroendocrinology·2009
Same author

A base-labile protecting group (fluorenylmethoxycarbonyl) for the 5'-hydroxy function of nucleosides.

Current protocols in nucleic acid chemistry·2008
Same author

Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.

Journal of peptide science : an official publication of the European Peptide Society·2008
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

High-resolution protein structures are revolutionizing HIV-1 and AIDS drug development. This knowledge impacts the design of drugs targeting key viral enzymes and protein-RNA interactions.

Area of Science:

  • Structural biology
  • Virology
  • Drug discovery

Background:

  • Human Immunodeficiency Virus type 1 (HIV-1) and Acquired Immunodeficiency Syndrome (AIDS) drug development.
  • The critical role of viral proteins in HIV-1 replication.
  • The need for novel therapeutic targets.

Purpose of the Study:

  • To survey the impact of structural knowledge on HIV-1 drug design.
  • To highlight the importance of elucidated structures of essential viral proteins.
  • To identify new targets for antiviral therapies.

Main Methods:

  • Review of recent structural studies of HIV-1 proteins.
  • Analysis of structure-based drug design strategies.
  • Examination of gene regulatory protein-RNA interactions.

Related Experiment Videos

Main Results:

  • High-resolution structures of reverse transcriptase and protease have significantly advanced drug design.
  • Structural insights into viral integrase offer new therapeutic avenues.
  • Understanding Tat-TAR and Rev-RRE interactions provides novel targets for intervention.

Conclusions:

  • Structural biology is a key driver in developing effective HIV-1 and AIDS treatments.
  • Elucidated protein structures enable rational drug design against viral targets.
  • Further exploration of viral protein structures and interactions will accelerate drug discovery.